Molecular basis of classic galactosemia from the structure of human galactose 1-phosphate uridylyltransferase.

作者: Thomas J. McCorvie , Jolanta Kopec , Angel L. Pey , Fiona Fitzpatrick , Dipali Patel

DOI: 10.1093/HMG/DDW091

关键词:

摘要: Classic galactosemia is a potentially lethal disease caused by the dysfunction of galactose 1-phosphate uridylyltransferase (GALT). Over 300 disease-associated GALT mutations have been reported, with majority being missense changes, although better understanding their underlying molecular effects has hindered lack structural information for human enzyme. Here, we present 1.9 A resolution crystal structure (hGALT) ternary complex, revealing homodimer arrangement that contains covalent uridylylated intermediate and glucose-1-phosphate in active site, as well zinc-binding per monomer. hGALT reveals significant differences from bacterial homologues metal ligation dimer interactions, therefore zbetter model consequences mutations. Both uridylylation zinc binding influence stability aggregation tendency hGALT. This implications variants where p.Gln188Arg, most commonly detected, increases rate absence likely due to its reduced ability form intermediate. As such our serves template future design pharmacological chaperone therapies opens new concepts about roles activity protein misfolding mutants.

参考文章(62)
L. Wells, J. L. Fridovich-Keil, Biochemical characterization of the S135L allele of galactose-1-phosphate uridylyltransferase associated with galactosaemia Journal of Inherited Metabolic Disease. ,vol. 20, pp. 633- 642 ,(1997) , 10.1023/A:1005314207513
Ana I Coelho, Matilde Trabuco, Maria João Silva, Isabel Tavares de Almeida, Paula Leandro, Isabel Rivera, João B Vicente, None, Arginine Functionally Improves Clinically Relevant Human Galactose-1-Phosphate Uridylyltransferase (GALT) Variants Expressed in a Prokaryotic Model JIMD reports. ,vol. 23, pp. 1- 6 ,(2015) , 10.1007/8904_2015_420
Thomas J. McCorvie, Tyler J. Gleason, Judith L. Fridovich-Keil, David J. Timson, Misfolding of galactose 1-phosphate uridylyltransferase can result in type I galactosemia. Biochimica et Biophysica Acta. ,vol. 1832, pp. 1279- 1293 ,(2013) , 10.1016/J.BBADIS.2013.04.004
J. Patrick Elsevier, Judith L. Fridovich-Keil, The Q188R Mutation in Human Galactose-1-phosphate Uridylyltransferase Acts as a Partial Dominant Negative Journal of Biological Chemistry. ,vol. 271, pp. 32002- 32007 ,(1996) , 10.1074/JBC.271.50.32002
Noel Mesa-Torres, Israel Fabelo-Rosa, Debora Riverol, Cristina Yunta, Armando Albert, Eduardo Salido, Angel L. Pey, The Role of Protein Denaturation Energetics and Molecular Chaperones in the Aggregation and Mistargeting of Mutants Causing Primary Hyperoxaluria Type I PLoS ONE. ,vol. 8, pp. e71963- ,(2013) , 10.1371/JOURNAL.PONE.0071963
Kenneth J. Valenzano, Richie Khanna, Allan C. Powe, Robert Boyd, Gary Lee, John J. Flanagan, Elfrida R. Benjamin, Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders. Assay and Drug Development Technologies. ,vol. 9, pp. 213- 235 ,(2011) , 10.1089/ADT.2011.0370